You are here

  • Home
  • Archive
  • Volume 8, Issue 9
  • Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Citation Tools

Article menu

Download PDFPDF

XML
Oncology
Protocol
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mersiades AJ, Tognela A, Haber PS, et al
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)
BMJ Open 2018;8:e020745. doi: 10.1136/bmjopen-2017-020745